Anemia of Chronic Disease: Unravelling New Pathways Beyond Iron Abstract Anemia of chronic disease (ACD) represents the second most common form of anemia worldwide, affecting millions of patients with underlying inflammatory conditions. Traditionally understood as a disorder primarily involving disruption of iron metabolism, recent
Hematology
Hidden Dangers of Iron Overload: Latest Chelation Therapy Breakthroughs in Hematology
Hidden Dangers of Iron Overload: Latest Chelation Therapy Breakthroughs in Hematology Check out our extensive video library (see channel for our latest videos) Introduction Iron overload remains a major cause of morbidity and mortality in patients with chronic hematologic disorders, particularly those who
Transfusion Medicine in the Genomic Era: Matching Beyond ABO and Rh
Transfusion Medicine in the Genomic Era Matching Beyond ABO and Rh Check out our extensive video library (see channel for our latest videos) Abstract Blood transfusion medicine is undergoing a significant transformation driven by rapid advances in genomic technology. For more than a century, the ABO
FDA-Approved ADCs: Breaking New Ground in Breast, Lung, and Gastric Cancer Treatment
FDA-Approved ADCs: Breaking New Ground in Breast, Lung, and Gastric Cancer Treatment Check out our extensive video library (see channel for our latest videos) Introduction FDA-approved ADCs are revolutionizing cancer treatment landscapes, as the fifth most prevalent malignancy globally, gastric cancer ranks
Critical Updates in TP53 MDS Prognosis: 2025 Findings
Hemophilia Prophylaxis in the Era of Non-Factor Therapies
Hemophilia Prophylaxis in the Era of Non-Factor Therapies Check out our extensive video library (see channel for our latest videos) Abstract Hemophilia treatment has changed dramatically with the introduction of non-factor therapies. This paper examines how these new treatments affect prophylactic care for
Breaking Research: MRD Positive Status Predicts Leukemia Outcomes
Breaking Research MRD Positive Status Predicts Leukemia Outcomes Introduction Minimal residual disease (MRD) status has emerged as one of the most powerful prognostic markers in leukemia management, fundamentally transforming how clinicians assess treatment response and long-term outcomes. MRD-positive status profoundly influences survival outcomes, as demonstrated
CRISPR vs Gene Therapy for Sickle Cell: Which Treatment Works Better?
CRISPR vs Gene Therapy for Sickle Cell: Which Treatment Works Better? Introduction Sickle cell disease (SCD) remains one of the most prevalent inherited hematologic disorders globally, affecting millions of individuals across diverse populations. It is estimated that approximately 100,000 people in the United States live
The Spectrum of AI Influence- Comparative Impact Across Medical Specialties
Will AI Replace Pathologists? The Truth from Leading Hematology Labs in 2025
